|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
13,380,000 |
Market
Cap: |
202.44(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$11.6 - $15.13 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Merrimack Pharmaceuticals is a biopharmaceutical company. Co. does not have any ongoing research or development activities.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) ![](../../images/information.jpg) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
49,550 |
504,050 |
1,155,305 |
Total Buy Value |
$0 |
$651,754 |
$6,240,948 |
$13,468,612 |
Total People Bought |
0 |
1 |
2 |
4 |
Total Buy Transactions |
0 |
2 |
13 |
36 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Sinskey Anthony J |
Director |
|
2012-08-01 |
4 |
OE |
$2.19 |
$43,800 |
D/D |
20,000 |
406,518 |
|
- |
|
Dresser James Van B. |
Director |
|
2012-07-24 |
4 |
OE |
$2.19 |
$43,800 |
D/D |
20,000 |
128,974 |
|
- |
|
Nielsen Ulrik B. |
SVP and CSO |
|
2012-07-16 |
4 |
OE |
$2.19 |
$9,566 |
D/D |
4,368 |
251,811 |
|
- |
|
Fehr Gordon J. |
Director |
|
2012-07-03 |
4 |
OE |
$2.19 |
$43,800 |
D/D |
20,000 |
190,143 |
|
- |
|
Mulroy Robert J. |
President and CEO |
|
2012-06-15 |
5 |
OE |
$2.19 |
$164,250 |
D/D |
75,000 |
840,811 |
|
- |
|
Mulroy Robert J. |
President and CEO |
|
2012-06-15 |
4 |
OE |
$2.19 |
$164,250 |
D/D |
75,000 |
680,819 |
|
- |
|
Loverberg Walter |
Director |
|
2012-04-25 |
4 |
OE |
$2.19 |
$11,962 |
D/D |
5,462 |
84,033 |
|
- |
|
Sinskey Anthony J |
Director |
|
2012-04-19 |
4 |
OE |
$2.19 |
$11,962 |
D/D |
5,462 |
386,518 |
|
- |
|
Fehr Gordon J. |
Director |
|
2012-04-17 |
4 |
OE |
$2.19 |
$11,962 |
D/D |
5,462 |
170,143 |
|
- |
|
Dresser James Van B. |
Director |
|
2012-04-10 |
4 |
OE |
$2.19 |
$11,962 |
D/D |
5,462 |
108,974 |
|
- |
|
Mulroy Robert J. |
President and CEO |
|
2012-04-03 |
5 |
A |
$0.00 |
$0 |
I/I |
159,992 |
765,811 |
|
- |
|
Sinskey Anthony J |
Director |
|
2012-04-03 |
4 |
A |
$0.00 |
$0 |
I/I |
18,024 |
381,056 |
|
- |
|
Sinskey Anthony J |
Director |
|
2012-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
36,723 |
363,032 |
|
- |
|
Sinskey Anthony J |
Director |
|
2012-04-03 |
4 |
B |
$7.00 |
$49,994 |
D/D |
7,142 |
326,309 |
2.39 |
- |
|
Porter Michael E |
Director |
|
2012-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
177,365 |
252,865 |
|
- |
|
Porter Michael E |
Director |
|
2012-04-03 |
4 |
B |
$7.00 |
$87,500 |
D/D |
12,500 |
75,500 |
2.39 |
- |
|
Dresser James Van B. |
Director |
|
2012-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
16,012 |
103,512 |
|
- |
|
Gay Robert C |
Director |
|
2012-04-03 |
4 |
A |
$0.00 |
$0 |
I/I |
318,173 |
636,346 |
|
- |
|
Gay Robert C |
Director |
|
2012-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
318,173 |
318,173 |
|
- |
|
Fehr Gordon J. |
Director |
|
2012-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
22,222 |
164,681 |
|
- |
|
Fehr Gordon J. |
Director |
|
2012-04-03 |
4 |
B |
$7.00 |
$9,996 |
D/D |
1,428 |
142,459 |
2.39 |
- |
|
Crocker Gary L |
Director |
|
2012-04-03 |
4 |
A |
$0.00 |
$0 |
I/I |
1,364,674 |
2,430,031 |
|
- |
|
Crocker Gary L |
Director |
|
2012-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
925,359 |
1,065,357 |
|
- |
|
Crocker Gary L |
Director |
|
2012-04-03 |
4 |
B |
$7.00 |
$529,991 |
I/I |
75,713 |
139,998 |
2.1 |
- |
|
Crocker Gary L |
Director |
|
2012-04-03 |
4 |
B |
$7.00 |
$449,995 |
D/D |
64,285 |
64,285 |
2.39 |
- |
|
410 Records found
|
|
Page 16 of 17 |
|
|